fbpx
YoutubeInstagram

THE LATEST

Why Redefining Alzheimer’s as a “Biological” Condition Is Harmful, and Why the International Working Group Is Pushing Back
Latest Blog Post »
PTSD – The Powerfully Therapeutic Role of Hyperbaric Oxygen | Dr. Mohammed Elamir
Latest Video »
A Mysterious Epidemic and its Relationship to Global Health
Latest Chimera Post »

LEARN

Focus Topics
ADD/ADHDAlzheimer's and DementiaAutism Spectrum DisorderCoronavirusDiabetesExerciseGluten-FreeGMOKetogenicLow-CarbMagnesiumMental HealthMultiple SclerosisParkinson's DiseasePregnant and NursingSleepStressSupplementsUric AcidVegetarianWeight Loss

BOOKS

NEW BOOK
Brain Defenders
In Brain Defenders, David Perlmutter, MD, introduces a revolutionary understanding of neurodegenerative dise...
Learn More »

ABOUT

David Perlmutter, MD
Meet America’s Neurologist™
The Latest
Learn
Books
About
YoutubeInstagram

Alzheimer’s

Reflecting on CBS This Morning
December 19, 2018

Reflecting on CBS This Morning

Alzheimer’s Drugs Worsen Cognitive Function
December 7, 2018

Alzheimer’s Drugs Worsen Cognitive Function

It’s becoming quite common these days to see news releases documenting the failure of yet another experimental drug for the treatment of Alzheimer’s disease. In fact, one major pharmaceutical company, Pfizer...
Yes – Alzheimer’s Can be Reversed!
December 5, 2018

Yes – Alzheimer’s Can be Reversed!

I’ve often been quoted as stating that there is no pharmaceutical approach that has meaningful effectiveness on the treatment of Alzheimer’s disease. Unfortunately, I have to continue to make this claim. As ...
Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease
December 5, 2018

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials
November 26, 2018

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
November 14, 2018

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition

Midlife hypertension and 20-year cognitive change: The Atherosclerosis Risk in Communities Neurocognitive Study
November 14, 2018

Midlife hypertension and 20-year cognitive change: The Atherosclerosis Risk in Communities Neurocognitive Study

Is Alzheimer’s disease a Type 3 Diabetes? A Critical Appraisal
November 14, 2018

Is Alzheimer’s disease a Type 3 Diabetes? A Critical Appraisal

The Science Behind Why “Low Alcohol” Wine Matters for Your Health
November 6, 2018

The Science Behind Why “Low Alcohol” Wine Matters for Your Health

By: The Dr. Perlmutter Team Alcohol is one of the most controversial topics health and wellness practitioners must navigate. Frequently, readers of this blog ask if alcohol consumption can be a part of a he...
A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer’s Disease: The AIBL Active-Study
November 5, 2018

A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer’s Disease: The AIBL Active-Study

Reversal of Cognitive Decline: 100 Patients
November 5, 2018

Reversal of Cognitive Decline: 100 Patients